0001493152-21-009408.txt : 20210421 0001493152-21-009408.hdr.sgml : 20210421 20210421215150 ACCESSION NUMBER: 0001493152-21-009408 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210416 FILED AS OF DATE: 20210421 DATE AS OF CHANGE: 20210421 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kaplin Adam CENTRAL INDEX KEY: 0001858042 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36268 FILM NUMBER: 21843099 MAIL ADDRESS: STREET 1: C/O AKERS BIOSCIENCES, INC. STREET 2: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MyMD Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001321834 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1185 AVENUE OF THE AMERICAS STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 856-848-8698 MAIL ADDRESS: STREET 1: 1185 AVENUE OF THE AMERICAS STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 FORMER COMPANY: FORMER CONFORMED NAME: Akers Biosciences, Inc. DATE OF NAME CHANGE: 20170413 FORMER COMPANY: FORMER CONFORMED NAME: Akers Biosciences Inc DATE OF NAME CHANGE: 20050325 3 1 ownership.xml X0206 3 2021-04-16 1 0001321834 MyMD Pharmaceuticals, Inc. MYMD 0001858042 Kaplin Adam 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 0 1 0 0 Chief Scientific Officer /s/ Adam Kaplin 2021-04-21